Home > Healthcare > Medical Devices > Rehabilitation and Assistive Devices > Diabetic Footwear Market

Diabetic Footwear Market Analysis

  • Report ID: GMI6062
  • Published Date: Jun 2023
  • Report Format: PDF

Diabetic Footwear Market Analysis

Based on product, the diabetic footwear market is segmented as shoes, slippers, sneakers, sandals, and socks. The shoes segment held the dominant market share in 2022 and was valued at over USD 2.3 billion. This dominant market share is attributable to the growing diabetic population, increasing awareness, and the advent of innovative features among others. The rising prevalence of diabetes globally is a significant driver for the growth of the diabetic shoes segment.
 

As per the International Diabetes Federation, in 2021, around 537 million adults were living with diabetes across the world. The demand for specialized footwear that offers comfort and protection will increase significantly as more people are diagnosed with diabetes. There is a growing awareness among diabetic patients about the importance of diabetes care devices to prevent complications such as foot ulcers and neuropathy. This awareness has resulted in a higher demand for diabetic shoes that are specifically designed to provide proper support and reduce the risk of injuries. Additionally, the diabetic shoes segment has witnessed technological advancements along with innovative features comprising cushioning, breathable materials, and moisture-wicking properties among others.
 

Global Diabetic Footwear Market, By Foot Condition (2023)

Based on foot condition, the market is segmented as neuropathy, ulcers, and deformities. The neuropathy segment accounted for a dominant diabetic footwear market share in 2022 and was valued at over USD 3.3 billion. This high segmental revenue share is owing to the diabetic footwear that can provide several advantages in treating neuropathy, that is a common complication of diabetes. Neuropathy can cause a loss of sensation in the feet, making it difficult for individuals to detect injuries or irritations.
 

Diabetic footwear often includes protective elements such as a wider toe box, seamless interior, and soft padding to minimize the risk of skin breakdown, blisters, or abrasions. These wearable medical devices create a barrier between the foot and potential sources of friction or trauma. Nerve damage from neuropathy can affect the muscles and joints of the feet, leading to instability and balance issues. Diabetic footwear typically incorporates features including firm heel counters, supportive midsoles, and adjustable closures to provide stability & promote proper alignment. This can help reduce the risk of falls and related injuries. Hence, several benefits provided by diabetic footwear in neuropathy treatment will spur the business growth.
 

Based on distribution channel, the market is segmented as supermarkets & hypermarkets, pharmacy stores, online stores, and others. The online stores segment held a considerable market share in 2022 and was valued at around USD 1.9 billion. The rise of e-commerce platforms and online retail has had a significant impact on the diabetic footwear market. It has made it easier for individuals to access a wider range of options and make purchases conveniently from the comfort of their homes. Online platforms also provide detailed product information, customer reviews, and size guides to help customers make informed decisions. This data helps customers make informed decisions that are suitable as per their condition and preferences.
 

Moreover, online stores provide more competitive pricing for diabetic footwear as online retailers often have lower overhead costs compared to physical stores. Owing to this, customer may find better deals & discounts online, enabling them to save money on their purchases. As a result, numerous advantages associated with the online stores will upsurge the industry growth.
 

Based on end-use, the diabetic footwear market is segmented as men, women, and kids. The men segment is projected to reach more than USD 7.2 billion by the end of 2032. The preference for diabetic footwear in the male population has been increasing over the years due to several factors. Men with diabetes are more prone to foot complications such as neuropathy, poor circulation, and increased risk of diabetic ulcers. Diabetic footwear is specifically designed to address these issues by providing proper support, cushioning, and minimizing pressure points, reducing the risk of developing foot problems.

Diabetic footwear typically features soft, seamless interiors to prevent friction and irritation, that can lead to blisters & sores. They also have wider and deeper toe boxes to accommodate any deformities or swelling. These features contribute to overall comfort and protection for men with diabetes. Diabetic shoes are designed to distribute body weight evenly across the feet, that helps alleviate pressure on specific areas. This feature is crucial for individuals with foot deformities, ulcers, or other conditions that require offloading pressure from certain areas. As a result, comfort, injury prevention, and expansion in design choices among others has augmented the segment growth.
 

U.S. Diabetic Footwear Market, 2020- 2032 (USD Billion)

U.S. dominated the North America diabetic footwear market with a significant market share in 2022 and is anticipated to expand at a considerable pace to reach around USD 4.6 billion by 2032. The U.S. market for diabetic footwear has been experiencing steady growth in recent years, primarily driven by factors such as the increasing prevalence of diabetes, a growing geriatric population, and rising awareness about the importance of foot care among diabetic individuals. The U.S. has a high prevalence of diabetes, with both type 1 and type 2 diabetes being significant health concerns.
 

For instance, as per the Diabetes Research Institute report 2022, around 37 million people were suffering with diabetes in the U.S. The demand for specialized diabetic footwear is expected to rise as the number of people living with diabetes continues to upsurge. The aging population in the U.S. is a major driver for the diabetic footwear market. Older individuals are more expected to develop diabetes & associated foot-related complications, such as neuropathy and poor circulation. As a result, they require proper footwear to prevent injuries and ulcers.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Marker size for diabetic footwear was worth USD 7.2 billion in 2023 and is set to reach over USD 11.9 billion by 2032, driven by the surging need for improved quality and functionality of diabetic through advanced manufacturing techniques.

Diabetic footwear industry share from the shoe product segment exceeded USD 2.3 billion in 2022 propelled by the growing diabetic population, increasing awareness, and the advent of innovative features.

U.S. diabetic footwear valuation is estimated to reach USD 4.6 billion by 2032 attributed to the increasing prevalence of diabetes and the growing awareness about the importance of foot care among diabetic individuals.

Some of the major diabetic footwear players include Aetrex Worldwide, Apex Foot Health Industries, LLC, DJO Global Inc., Dr. Comfort, Dr. Zen Products Inc., Drew Shoe Corporation, Finn Comfort among others.

Diabetic Footwear Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 454
  • Countries covered: 30
  • Pages: 180
 Download Free Sample